JERUSALEM, Feb. 28, 2017 /PRNewswire/ -- Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that the first patient has been transplanted in the Company's Phase 3 study of NiCord®, in development as a cure for patients with blood cancer who do not have [...]
10 Aug, 2015 15:07 Gali Weinreb The Israeli company will use the investment to fund US trials for its needle steering technology. XACT Robotics, an Israeli startup developing novel platform robotic technology for use in minimally invasive procedures has raised $5 million. The latest round of funding was led by MEDX Ventures Group, which founded [...]
Prescriptions can be complicated and confusing, especially for patients taking more than one set of pills. But when people don’t properly follow their prescription plans, it can lead to deteriorating health, additional hospital visits, and potentially life-threatening episodes. The costs are high for the healthcare industry, too. Studies have estimated that more than $100 billion [...]
by Nick Paul Taylor | Feb 27, 2017 7:34am Pharma Two B will run a phase 3 of its pramipexole-rasagiline fixed-dose combination P2B001. Pharma Two B has raised $30 million (€28 million) to complete a phase 3 trial of its Parkinson’s asset P2B001. The round provides a hint of the impact of the recently founded [...]
Medical device innovation doesn’t just come from small, single-product startups – contract manufacturers are increasingly a part of developing truly disruptive medtech. Chris Newmarker, Managing Editor People sometimes make the mistake of viewing innovation as the product of a few geniuses and mavericks. But in fact, it is often the result of teamwork, as the [...]
Listen to Medtech Insight's podcast on selected Israeli medical device & digital health companies that was broadcast this week. On this week's Medtech Insight podcast: the response by a US FDA advisory panel to Claret Medical's de novo submission for the first brain-filter device intended to protect patients undergoing transcatheter aortic heart valve replacement; a [...]
Genetically engineered T-cells treat leukemia in babies February 16, 2017 By Danielle Kirsh Researchers in London have successfully treated leukemia in two babies, in what they are touting as the world’s first treatment of cancer using genetically engineered immune cells from donors.Doctors treated two British infants, 11 and 16 months old, using Cellectis’s CAR T-cell [...]
Hemonitor measures blood flow in the main artery of intensive care patients. The MindUP technology incubator, a partnership between Pitango Venture Capital, the Rambam Health Care Campus, medical device company Medtronic, IBM, and the Impact First investment fund, has accepted its first company - Hemonitor.Hemonitor measures blood flow in the main artery of patients arriving [...]
Catherine Longworth@MedtechCate [email protected] Executive Summary An analytics platform developed by Israeli big data company Intensix has shown high accuracy for detecting and predicting sepsis in critical care. The positive results were presented at the Healthcare Information and Management Systems Society (HIMSS) healthcare IT conference in Orlando, Florida. A new study has shown that an analytics [...]
Israel's BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS), a neuro-degenerative disease, even before it completes late-stage clinical trials. BrainStorm said on Tuesday that it had signed an agreement with CCRM, a Canadian not-for-profit organization that supports development of regenerative medicine, [...]